Relación entre obesidad y desarrollo de insuficiencia renal

Weisinger, 1974, The nephrotic syndrome: A complication of massive obesity, Ann Intern Med, 81, 440, 10.7326/0003-4819-81-4-440 Verani, 1992, Obesity-associated focal segmental glomerulos-clerosis: pathological features of the lesions and relationship with cardiomegaly and hyperlipidemia, Am J Kidney Dis, 20, 629, 10.1016/S0272-6386(12)70230-5 Kambham, 2001, Obesity-related glomerulopathy: an emerging epidemic, Kidney Int, 59, 1498, 10.1046/j.1523-1755.2001.0590041498.x Fox, 2004, Predictors of new-onset kidney disease in a community-based population, JAMA, 291, 844, 10.1001/jama.291.7.844 Must, 1999, The disease burden associated with overweight and obesity, JAMA, 282, 1523, 10.1001/jama.282.16.1523 Hsu, 2006, Body mass index and risk for end-stage renal disease, Ann Intern Med, 144, 21, 10.7326/0003-4819-144-1-200601030-00006 Gelber, 2005, Association between body mass index and CKD in apparently healthy men, Am J Kidney Dis, 46, 871, 10.1053/j.ajkd.2005.08.015 Kramer, 2005, Obesity and prevalent and incident CKD: the hipertensión detection and follow-up program, Am J Kidney Dis, 46, 587, 10.1053/j.ajkd.2005.06.007 Praga, 2002, Obesity- a neglected culprit in renal disease, Nephrol Dial Transplant, 17, 1157, 10.1093/ndt/17.7.1157 Kasiske, 1985, Glomerular sclerosis in patients with massive obesity, Am J Nephrol, 5, 45, 10.1159/000166902 Praga, 2001, Clinical features and long term outcome of obesity-associated focal segmental glomeruloescle- rosis, Nephrol Dial Transplant, 16, 1790, 10.1093/ndt/16.9.1790 Adelman, 2001, Proteinuria and focal segmental glomeruloesclerosis in severy obese adolescents, J Pediatr, 138, 481, 10.1067/mpd.2001.113006 Praga, 1998, Disminución de masa renal funcionante y proteinuria, Nefrología, 18, 17 Praga, 1991, Nephrotic proteinuria without hypoalbuminemia: clinical characteristics and response to angiotensin converting enzyme inhibition, Am J Kidney Dis, 17, 330, 10.1016/S0272-6386(12)80483-5 Praga, 1999, Absence of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltration, Am J Kidney Dis, 33, 52, 10.1016/S0272-6386(99)70257-X D’Agati, 1994, The many masks of focal segmental glomerulosclerosis, Kidney Int, 46, 1223, 10.1038/ki.1994.388 Henegar, 2001, Functional and structural changes in the kidney in the early stages of obesity, J Am Soc Nephrol, 12, 1211, 10.1681/ASN.V1261211 Adelman, 2002, Obesity and renal disease, Curr Opin Nephrol Hypertens, 11, 331, 10.1097/00041552-200205000-00010 Praga, 2006, Obesity, proteinuria and progression of renal failure, Curr Opin Nephrol Hypertens, 15, 481, 10.1097/01.mnh.0000242172.06459.7c Hall, 1998, Abnormal kidney function as a cause and a consequence of obesity hypertension, Clin Exp Pharmacol Physiol, 25, 58, 10.1111/j.1440-1681.1998.tb02146.x Chagnac, 2000, Glomerular hemodynamics in severe obesity, Am J Physiol, 278, F817 Chagnac, 2003, The effects of weight loss on renal function in patients with severe obesity, J Am Soc Nephrol, 14, 1480, 10.1097/01.ASN.0000068462.38661.89 Hall, 2003, The kidney, hypertension and obesity, Hypertension, 41, 625, 10.1161/01.HYP.0000052314.95497.78 Bickel, 2001, Increased renal Na-K-ATPase, NCC, and beta-ENaC abundance in obese Zucker rats, Am J Physiol Renal Physiol, 281, F639, 10.1152/ajprenal.2001.281.4.F639 Jiang, 2005, Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulo- esclerosis via a sterol regulatory element-binding protein1c-dependent pathway, J Biol Chem, 280, 32317, 10.1074/jbc.M500801200 Bagby, 2004, Obesity-initiated metabolic síndrome and the kidney: a recipe for chronic kidney disease?, J Am Soc Nephrol, 15, 2775, 10.1097/01.ASN.0000141965.28037.EE El-Atat, 2004, The relationship between hiperinsulinemia, hipertensión and progressive renal disease, J Am Soc Nephrol, 15, 2816, 10.1097/01.ASN.0000133698.80390.37 Blanco, 2005, Potential role of angiotensina-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity and mild hypertension, Am J Hypertens, 18, 557, 10.1016/j.amjhyper.2004.10.034 Engeli, 2005, Weight loss and the renin-angiotensin-aldosterone system, Hypertension, 45, 356, 10.1161/01.HYP.0000154361.47683.d3 De Paula, 2004, Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration, Hypertension, 43, 41, 10.1161/01.HYP.0000105624.68174.00 Ehrhart-Bornstein, 2003, Human adipocytes secrete mineralocorticoid-releasing factors, Proc Natl Acad Sci USA, 10, 14211, 10.1073/pnas.2336140100 Hostetter, 2003, Aldosterone in chronic kidney and cardiac disease, J Am Soc Nephrol, 14, 2395, 10.1097/01.ASN.0000086472.65806.73 Frystyk, 1999, Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes, Diabetes Metab Res Rev, 1 5, 314, 10.1002/(SICI)1520-7560(199909/10)15:5<314::AID-DMRR56>3.0.CO;2-E Baylis, 2003, Peroxisome proliferator-activated receptor [gamma] agonist provides superior renal protection versus angiotensina-converting enzyme inhibition in a rat model of tipe 2 diabetes with obesity, J Pharmacol Exp Ther, 307, 854, 10.1124/jpet.103.055616 Wolf, 1999, Leptin stimulates proliferation and TGF-β expression in renal glomerular endothelial cells. Potential role in glomerulosclerosis, Kidney Int, 56, 860, 10.1046/j.1523-1755.1999.00626.x Ziyadeh, 2000, Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice, Proc Natl Acad Sci USA, 97, 8015, 10.1073/pnas.120055097 Stevenson, 2000, Estrogen worsens incipient hypertryglyciridemic glomerular injury in the obese Zucker rat, Kidney Int, 57, 1927, 10.1046/j.1523-1755.2000.00042.x Nangaku, 2005, In a type 2 diabetic nephropathy rat model, the improvement of obesity by a low calorie diet reduces oxidative/carbonyl stress and prevents diabetic nephropathy, Nephrol Dial Transplant, 20, 2661, 10.1093/ndt/gfi096 Wu, 2006, Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples, Endocrinology, 147, 44, 10.1210/en.2005-0641 Brenner, 1982, Dietary protein intake and the progressive nature of kidney disease: the role of hemodinamically mediated injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation and intrinsic renal disease, N Engl J Med, 307, 652, 10.1056/NEJM198209093071104 Praga, 2005, Sinergy of low nephron number and obesity: a new focus on hyperfiltration nephropathy, Nephrol Dial Transplant, 20, 2594, 10.1093/ndt/gfi201 Praga, 2000, Influence of obesity on the appearance of proteinuria and renal insufficienciy alter unilateral uninephrectomy, Kidney Int, 58, 2111, 10.1111/j.1523-1755.2000.00384.x González, 2005, Factors influencing the progresión of renal damage in patients with unilateral renal agenesis and remmant kidney, Kidney Int, 68, 263, 10.1111/j.1523-1755.2005.00401.x Curhan, 1996, Birth weight and adult hypertension, diabetes mellitus and obesity in US men, Circulation, 94, 3246, 10.1161/01.CIR.94.12.3246 Morales, 2003, Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies, Am J Kidney Dis, 41, 319, 10.1053/ajkd.2003.50039 Soto, 2005, Renal failure, glomerulonephritis and morbid obesity: improvement after rapid weight loss following laparoscopic gastric by-pass, Obes Surg, 15, 137, 10.1381/0960892052993413 Palomar, 2005, Effects of weight loss after biliopancreatic diversion on metabolism and cardiovascular profile, Obes Surg, 15, 794, 10.1381/0960892054222687 Jafar, 2001, Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data, Ann Intern Med, 135, 73, 10.7326/0003-4819-135-2-200107170-00007 Praga, 1995, Effects of body-weight loss and captopril treatment on proteinuria associated with obesity, Nephron, 70, 35, 10.1159/000188541